在晚期肝癌中使用吉西他滨的联合放化疗OACSTPCD
Concomitant chemoradiation using gemcitabine in locally advanced hepatocellular carcinoma
Objective: Hepatocellular carcinoma (HCC) is among the most common and rapidly increasing cancers in Pakistan. There is currently no standard management for advanced HCC. The aim of the study was to assess response rate and toxicity of concomitant gemcitabine and external radiation therapy (ERT) in locally advanced HCC. Methods: Sixty patients were enrolled. Gemcitabine, 70 mg/m2 was given weekly during ERT. ERT was delivered with 60Co beam up to 30.6 Gy, 1.…查看全部>>
Abdul Mateen;Abrar Ahmed Javed;Ahmed Ijaz Masood
Multan Institute of Nuclear Medicine and Radiotherapy (MINAR), Multan, PakistanDepartment of Radiotherapy and Oncology, Nishtar Hospital, Multan, PakistanDepartment of Radiotherapy and Oncology, Nishtar Hospital, Multan, Pakistan
chemotherapy gemcitabine hepatocellular carcinoma (HCC) radiotherapy
chemotherapy gemcitabine hepatocellular carcinoma (HCC) radiotherapy
《中德临床肿瘤学杂志（英文版）》 2012 (3)
130-133,4
评论